Preserved micturition after intradetrusor onabotulinumtoxinA injection for treatment of neurogenic bladder dysfunction in Parkinson’s disease

BACKGROUND: To assess the efficacy and safety of intradetrusor onabotulinumtoxinA (OnabotA) injection treatment in patients with neurogenic lower urinary tract dysfunction (NLUTD), especially for patients with Parkinson disease (PD). METHODS: PD patients refractory to oral antimuscarinic participate...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Urol
Auteurs principaux: Knüpfer, Stephanie C., Schneider, Susanne A., Averhoff, Mareike M., Naumann, Carsten M., Deuschl, Günther, Jünemann, Klaus-Peter, Hamann, Moritz F.
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2016
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5011793/
https://ncbi.nlm.nih.gov/pubmed/27596481
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-016-0174-2
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires